For example, in hepatocellular carcinoma (HCC), non-small cell lung carcinoma (NSCLC), bladder cancer, chronic myelogenous leukemia, and NHL13,16,17, SET8 functions largely as an oncogene. This evidence concerns the gene KMT5A and urinary bladder cancer.